Literature DB >> 23142630

Early impairment in a water-finding test in a longitudinal study of the Tg2576 mouse model of Alzheimer's disease.

Yasushi Kishimoto1, Erina Higashihara, Akiko Fukuta, Akira Nagao, Yutaka Kirino.   

Abstract

Behavioral assessments of mouse models of neurodegenerative disorders are useful for investigating the molecular basis of the pathologies of the diseases. Here, we investigated the utility of a water-finding test using a video tracking system as a tool for evaluating cognitive deficits in Alzheimer's disease model mice. Transgenic mice expressing mutant amyloid precursor protein that incorporated the Swedish mutation (Tg2576 mice) were tested for behavioral alterations at 3, 5, 6, or 10 months of age. Tg2576 mice, which are widely used as a model of Alzheimer's disease, exhibited significant cognitive deficits in the water-finding test as early as 5 months of age. The impairments progressively worsened at 6 and 10 months of age. In addition, we analyzed spontaneous physical activities, such as locomotor activity, in the home-cage environment with an automated video analysis system (HomeCageScan). Our longitudinal study revealed that spontaneous behavior was altered in the Tg2576 mice, starting at the age of 10 months. Impairment in the Morris water maze (MWM) task was also first observed in the Tg2576 mice at the age of 10 months. These results indicated that the ability to perform the water-finding test was more susceptible to age-related cognitive deterioration in Tg2576 mice than the MWM test. We therefore propose that the water-finding test is a rapid and sensitive method that can be used to assess cognitive and/or behavioral deficits in mouse models of Alzheimer's disease.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23142630     DOI: 10.1016/j.brainres.2012.10.066

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  Task-specific enhancement of hippocampus-dependent learning in mice deficient in monoacylglycerol lipase, the major hydrolyzing enzyme of the endocannabinoid 2-arachidonoylglycerol.

Authors:  Yasushi Kishimoto; Barbara Cagniard; Maya Yamazaki; Junko Nakayama; Kenji Sakimura; Yutaka Kirino; Masanobu Kano
Journal:  Front Behav Neurosci       Date:  2015-06-02       Impact factor: 3.558

2.  Deciphering the molecular profile of plaques, memory decline and neuron loss in two mouse models for Alzheimer's disease by deep sequencing.

Authors:  Yvonne Bouter; Tim Kacprowski; Robert Weissmann; Katharina Dietrich; Henning Borgers; Andreas Brauß; Christian Sperling; Oliver Wirths; Mario Albrecht; Lars R Jensen; Andreas W Kuss; Thomas A Bayer
Journal:  Front Aging Neurosci       Date:  2014-04-16       Impact factor: 5.750

3.  Defensive effect of microRNA-200b/c against amyloid-beta peptide-induced toxicity in Alzheimer's disease models.

Authors:  Sayuri Higaki; Masashi Muramatsu; Akio Matsuda; Kenji Matsumoto; Jun-Ichi Satoh; Makoto Michikawa; Shumpei Niida
Journal:  PLoS One       Date:  2018-05-08       Impact factor: 3.240

4.  Spatial and latent memory data in PS2Tg2576 alzheimer's disease mouse model after memantine treatment.

Authors:  Masahisa Matsumura; Kana Sato; Takashi Kubota; Yasushi Kishimoto
Journal:  Data Brief       Date:  2021-05-12

5.  Inhibition of MAO-A and stimulation of behavioural activities in mice by the inactive prodrug form of the anti-influenza agent oseltamivir.

Authors:  Miki Hiasa; Yumiko Isoda; Yasushi Kishimoto; Kenta Saitoh; Yasuaki Kimura; Motomu Kanai; Masakatsu Shibasaki; Dai Hatakeyama; Yutaka Kirino; Takashi Kuzuhara
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

6.  Decreased Myelinated Fibers in the Hippocampal Dentate Gyrus of the Tg2576 Mouse Model of Alzheimer's Disease.

Authors:  Wei Lu; Shu Yang; Lei Zhang; Lin Chen; Feng-Lei Chao; Yan-Min Luo; Qian Xiao; Heng-Wei Gu; Rong Jiang; Yong Tang
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

7.  A Novel Form of Compensation in the Tg2576 Amyloid Mouse Model of Alzheimer's Disease.

Authors:  Attila Somogyi; Zoltán Katonai; Alán Alpár; Ervin Wolf
Journal:  Front Cell Neurosci       Date:  2016-06-16       Impact factor: 5.505

8.  Early Contextual Fear Memory Deficits in a Double-Transgenic Amyloid-β Precursor Protein/Presenilin 2 Mouse Model of Alzheimer's Disease.

Authors:  Yasushi Kishimoto; Kai Fukumoto; Mika Nagai; Ayaka Mizuguchi; Yuiko Kobashi
Journal:  Int J Alzheimers Dis       Date:  2017-11-27

9.  Data on COA-Cl administration to the APP/PS2 double-transgenic mouse model of Alzheimer׳s disease: Improved hippocampus-dependent learning and unchanged spontaneous physical activity.

Authors:  Yasushi Kishimoto; Ikuko Tsukamoto; Atsuko Nishigawa; Akiko Nishimoto; Yutaka Kirino; Yoshihisa Kato; Ryoji Konishi; Tokumi Maruyama; Norikazu Sakakibara
Journal:  Data Brief       Date:  2018-09-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.